Avilar Therapeutics
Organisation
People
SVP and Head of Research
Chief Business Officer
Chief Development Officer
Chief Scientific Officer
Chief Executive Officer
Sources: avilar-tx.com
Based in
United States
Sources: avilar-tx.com
Funding rounds
Form D
US$75.3m, 14 Dec 2020
Sources: sec.gov
Named in competing interests
Consulting or advice, Board or leadership role, 25 Sept 2026
Proteomic signatures during pregnancy: an exploratory cohort study of long-term health indicators
Patents or royalties, 22 Sept 2026
Sources: pubmed.ncbi.nlm.nih.gov
Competes in
Sources: avilar-tx.com